We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

340B Program: U.S. District Court for the District of Columbia Vacates HRSA's Final Rule on the 340B Orphan Drug Exclusion

27 May 2014

Health, Pharmaceutical, and Biotechnology Alert

On Friday, May 23, 2014, the U.S. District Court for the District of Columbia "vacated," or invalidated, the Health Resources and Services Administration's (HRSA) final rule on the treatment of orphan drugs under the 340B Drug Discount Program. HRSA, which administers the 340B program, released the final rule in July 2013.

Read More: 340B Program: U.S. District Court for the District of Columbia Vacates HRSA's Final Rule on the 340B Orphan Drug Exclusion

The team

Loading data